Cardiovascular Devices Market Set for Strong Growth Through 2035, Fueled by Rising Heart Disease Burden, Minimally Invasive Technologies and Expanding Global Healthcare Investment

Dublin, Sept. 18, 2026 (GLOBE NEWSWIRE) -- "Cardiovascular Devices Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering.

Global Cardiovascular Devices Market to Reach USD 157.32 Billion by 2035 as Advanced Cardiac Technologies Accelerate

The global cardiovascular devices market is projected to expand from USD 74.58 billion in 2025 to USD 157.32 billion by 2035, registering a compound annual growth rate of 7.70% from 2026 to 2035. Market growth is being driven by the increasing prevalence of cardiovascular disease, rising demand for minimally invasive procedures, and continued innovation in cardiac diagnostics, monitoring systems, electrophysiology, and structural heart therapies.

Advanced technologies such as pulsed field ablation and next-generation transcatheter heart valve systems are transforming cardiovascular disease management. These platforms offer less invasive treatment options, improved procedural efficiency, and favorable clinical outcomes, supporting broader adoption among hospitals and specialty cardiovascular centers worldwide.

Competitive Landscape and Recent Market Developments

The cardiovascular devices market remains highly consolidated, with Medtronic, Abbott, Boston Scientific, and Edwards Lifesciences holding prominent competitive positions. These companies continue to prioritize investments in structural heart devices, electrophysiology platforms, minimally invasive cardiac therapies, and artificial intelligence-enabled diagnostic solutions.

Medtronic reported cardiovascular revenue of USD 3.44 billion in the second quarter of fiscal year 2026, representing organic growth of 9.3%. Performance was supported by the commercial expansion of the Sphere-9 Pulsed Field Ablation system and the Evolut FX transcatheter aortic valve platform. Edwards Lifesciences reported second-quarter 2025 sales of USD 1.53 billion, an increase of 11.9%, reflecting sustained demand for structural heart and valve therapies.

Key Cardiovascular Devices Market Growth Drivers

The rising global burden of cardiovascular disease remains the primary long-term demand driver. Approximately 12.1 million people in the United States are projected to be diagnosed with atrial fibrillation by 2030, increasing the need for advanced electrophysiology devices, ablation systems, implantable technologies, and long-term cardiac monitoring solutions.

Nearly 127.9 million U.S. adults were living with some form of cardiovascular disease as of 2024. This substantial patient population supports consistent demand across diagnostic, monitoring, therapeutic, and surgical device categories. Aging populations, increased screening activity, and the expansion of specialized cardiac care are also strengthening market prospects.

Artificial Intelligence Creates New Market Opportunities

Artificial intelligence-based cardiac diagnostics are improving the speed, accuracy, and efficiency of cardiovascular detection and monitoring workflows. Platforms such as AccuRhythm AI support the interpretation of complex cardiovascular datasets and facilitate the identification of arrhythmias and other cardiac abnormalities.

Machine learning technologies are increasingly being integrated into cardiac monitoring devices and clinical decision-support systems. This trend is expected to improve workflow efficiency, strengthen clinical decision-making, and increase the role of AI-enabled cardiovascular devices throughout modern care pathways.

Regulatory and Commercialization Challenges

Stringent regulatory requirements remain a significant barrier to cardiovascular device commercialization. Lengthy review processes conducted by the U.S. Food and Drug Administration and international regulatory authorities can delay clinical trials, product clearances, and commercial launches.

Extended approval timelines also increase development costs and execution risks, particularly for smaller manufacturers with limited capital resources. These conditions may continue to favor established cardiovascular device companies with extensive regulatory expertise, global distribution capabilities, and diversified product portfolios.

Cardiovascular Devices Market Segmentation

Therapeutic and surgical devices accounted for 77.5% of total revenue by device type, supported by the healthcare sector's continued transition toward minimally invasive cardiovascular interventions. These procedures can reduce complication risks and shorten recovery periods compared with conventional open surgery.

Coronary artery disease represented the leading application segment due to its persistent prevalence and major contribution to global mortality and disability. Hospitals remained the primary end-user segment because they manage acute cardiovascular emergencies and require continuous access to diagnostic, interventional, surgical, and monitoring equipment.

Regional Market Outlook

North America accounted for 45.68% of the global cardiovascular devices market in 2025. The region's leadership is supported by developed healthcare infrastructure, high cardiovascular disease prevalence, substantial healthcare expenditure, and rapid adoption of advanced cardiac technologies.

The United States remains a major commercialization center for premium cardiovascular device platforms, particularly pulsed field ablation systems. Boston Scientific generated more than USD 1 billion in early revenue, primarily driven by the rapid U.S. adoption of pulsed field ablation technology. This performance highlights strong provider readiness to integrate advanced electrophysiology solutions into clinical practice.

The market analysis covers North America, Europe, Asia Pacific, the Middle East and Africa, and South America. Key countries include the United States, Canada, Mexico, China, India, Japan, South Korea, Australia and New Zealand, the United Arab Emirates, Saudi Arabia, South Africa, Argentina, and Brazil.

Leading Cardiovascular Device Companies

With cardiovascular disease prevalence continuing to rise and healthcare providers increasingly adopting minimally invasive treatments, AI-enabled diagnostics, pulsed field ablation, and structural heart therapies, the global cardiovascular devices market is positioned for sustained expansion through 2035.

Key Attributes:

Key Topics Covered:

Chapter 1. Executive Summary: Global Cardiovascular Devices Market

Chapter 2. Report Description

2.1. Research Framework

2.1.1. Research Objective

2.1.2. Market Definitions

2.1.3. Market Segmentation

2.2. Research Methodology

2.2.1. Market Size Estimation

2.2.2. Qualitative Research

2.2.2.1. Primary & Secondary Sources

2.2.3. Quantitative Research

2.2.3.1. Primary & Secondary Sources

2.2.4. Breakdown of Primary Research Respondents, By Region

2.2.5. Data Triangulation

2.2.6. Assumption for Study

Chapter 3. Global Cardiovascular Devices Market Overview

3.1. Industry Value Chain Analysis

3.1.1. Raw Material Suppliers (Medical-Grade Metals, Polymers, Electronic Components)

3.1.2. Component Manufacturers (Sensors, Catheters, Leads, Valves)

3.1.3. Device Manufacturers (Stents, Pacemakers, Defibrillators, Heart Valves)

3.1.4. Distributors & Healthcare Providers (Hospitals, Cardiac Centers, Clinics)

3.1.5. End Users (Patients with Cardiovascular Diseases, Ambulatory Care Settings)

3.2. Industry Outlook

3.2.1. Rising Prevalence of Cardiovascular Diseases & Aging Population

3.2.2. Increasing Adoption of Minimally Invasive Procedures

3.2.3. Technology Trends (AI-Enabled Monitoring, Wearable Devices, Biocompatible Materials)

3.2.4. Expansion of Healthcare Infrastructure in Emerging Markets

3.3. PESTLE Analysis

3.4. Porter's Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitutes

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Growth and Outlook

3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035

3.6. Market Attractiveness Analysis

3.6.1. By Product Type

3.7. Actionable Insights (Analyst's Recommendations)

Chapter 4. Competition Dashboard

4.1. Market Concentration Rate

4.2. Company Market Share Analysis (Value %), 2025

4.3. Competitor Mapping & Benchmarking

Chapter 5. Global Cardiovascular Devices Market Analysis

5.1. Market Dynamics and Trends

5.1.1. Growth Drivers

5.1.2. Restraints

5.1.3. Opportunity

5.1.4. Key Trends

5.2. Market Size and Forecast, 2020-2035 (US$ Mn)

5.2.1. By Device Type

5.2.1.1. Key Insights

5.2.1.1.1. Diagnostic & Monitoring

5.2.1.1.1.1. ECG

5.2.1.1.1.2. Holter Monitors

5.2.1.1.1.3. Event Monitors

5.2.1.1.1.4. Implantable Loop Recorders

5.2.1.1.1.5. Echocardiogram

5.2.1.1.1.6. Pet Scan

5.2.1.1.1.7. MRI

5.2.1.1.1.8. Cardiac CT

5.2.1.1.1.9. Doppler Fetal Monitors

5.2.1.1.2. Therapeutic & Surgical Devices

5.2.1.1.2.1.1. Pacemakers

5.2.1.1.2.1.2. Stents

5.2.1.1.2.1.3. Catheters and accessories

5.2.1.1.2.1.4. Guidewires

5.2.1.1.2.1.5. Cannulae

5.2.1.1.2.1.6. Electrosurgical Procedures

5.2.1.1.2.1.7. Valves

5.2.1.1.2.1.8. Occlusion Devices

5.2.1.1.2.1.9. Others

5.2.2. By Application

5.2.2.1. Key Insights

5.2.2.1.1. Cardiac Arrhythmia

5.2.2.1.2. Coronary Artery Disease

5.2.2.1.3. Heart Failure

5.2.2.1.4. Others

5.2.3. By End User

5.2.3.1. Key Insights

5.2.3.1.1. Hospitals

5.2.3.1.2. Specialty Clinics

5.2.3.1.3. Others

5.2.4. By Region

5.2.4.1. Key Insights

5.2.4.1.1. North America

5.2.4.1.1.1. The U.S.

5.2.4.1.1.2. Canada

5.2.4.1.1.3. Mexico

5.2.4.1.2. Europe

5.2.4.1.2.1. Western Europe

5.2.4.1.2.1.1. The UK

5.2.4.1.2.1.2. Germany

5.2.4.1.2.1.3. France

5.2.4.1.2.1.4. Italy

5.2.4.1.2.1.5. Spain

5.2.4.1.2.1.6. Rest of Western Europe

5.2.4.1.2.2. Eastern Europe

5.2.4.1.2.2.1. Poland

5.2.4.1.2.2.2. Russia

5.2.4.1.2.2.3. Rest of Eastern Europe

5.2.4.1.3. Asia Pacific

5.2.4.1.3.1. China

5.2.4.1.3.2. India

5.2.4.1.3.3. Japan

5.2.4.1.3.4. South Korea

5.2.4.1.3.5. Australia & New Zealand

5.2.4.1.3.6. ASEAN

5.2.4.1.3.7. Rest of Asia Pacific

5.2.4.1.4. Middle East & Africa

5.2.4.1.4.1. UAE

5.2.4.1.4.2. Saudi Arabia

5.2.4.1.4.3. South Africa

5.2.4.1.4.4. Rest of MEA

5.2.4.1.5. South America

5.2.4.1.5.1. Argentina

5.2.4.1.5.2. Brazil

5.2.4.1.5.3. Rest of South America

Chapter 6. North America Cardiovascular Devices Market Analysis

6.1. Market Dynamics and Trends

6.1.1. Growth Drivers

6.1.2. Restraints

6.1.3. Opportunity

6.1.4. Key Trends

6.2. Market Size and Forecast, 2020-2035 (US$ Mn)

6.2.1. By Device Type

6.2.2. By Application

6.2.3. By End User

6.2.4. By Country

Chapter 7. Europe Cardiovascular Devices Market Analysis

7.1. Market Dynamics and Trends

7.1.1. Growth Drivers

7.1.2. Restraints

7.1.3. Opportunity

7.1.4. Key Trends

7.2. Market Size and Forecast, 2020-2035 (US$ Mn)

7.2.1. By Device Type

7.2.2. By Application

7.2.3. By End User

7.2.4. By Country

Chapter 8. Asia Pacific Cardiovascular Devices Market Analysis

8.1. Market Dynamics and Trends

8.1.1. Growth Drivers

8.1.2. Restraints

8.1.3. Opportunity

8.1.4. Key Trends

8.2. Market Size and Forecast, 2020-2035 (US$ Mn)

8.2.1. By Device Type

8.2.2. By Application

8.2.3. By End User

8.2.4. By Country

Chapter 9. Middle East & Africa Cardiovascular Devices Market Analysis

9.1. Market Dynamics and Trends

9.1.1. Growth Drivers

9.1.2. Restraints

9.1.3. Opportunity

9.1.4. Key Trends

9.2. Market Size and Forecast, 2020-2035 (US$ Mn)

9.2.1. By Device Type

9.2.2. By Application

9.2.3. By End User

9.2.4. By Country

Chapter 10. South America Cardiovascular Devices Market Analysis

10.1. Market Dynamics and Trends

10.1.1. Growth Drivers

10.1.2. Restraints

10.1.3. Opportunity

10.1.4. Key Trends

10.2. Market Size and Forecast, 2020-2035 (US$ Mn)

10.2.1. By Device Type

10.2.2. By Application

10.2.3. By End User

10.2.4. By Country

Chapter 11. Company Profiles (Company Overview, Company Timeline, Organization Structure, Key Product landscape, Financial Matrix, Key Customers/Sectors, Key Competitors, SWOT Analysis, Contact Address, and Business Strategy Outlook)

11.1. Abbott

11.2. BIOTRONIK SE & Co. KG

11.3. Boston Scientific Corporation

11.4. Canon Medical Systems

11.5. B. Braun SE

11.6. Cardinal Health

11.7. Medtronic

11.8. LivaNova PLC

11.9. Siemens Healthcare GmbH

11.10. Edwards Lifesciences Corporation

11.11. GE Healthcare

11.12. W. L. Gore & Associates, Inc.

11.13. Other Prominent Players

Chapter 12. Annexure

12.1. List of Secondary Sources

12.2. Key Country Markets - Macro Economic Outlook/Indicators

A selection of companies mentioned in this report includes, but is not limited to:

For more information about this report visit https://www.researchandmarkets.com/r/dufl2h

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.